Shared on 29 Aug 25

Fair value Increased 2.63%

The consensus analyst price target for Medibank Private has increased to A$5.05, primarily reflecting improved revenue growth forecasts despite a slight decline in net profit margin. Valuation Changes Summary of Valuation Changes for Medibank Private The Consensus Analyst Price Target has risen slightly from A$4.95 to A$5.05.

Read more

0 votesShare

Shared on 01 May 25

Fair value Increased 7.41%

Read more

0 votesShare

Shared on 23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

0 votesShare

Shared on 17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

0 votesShare

Shared on 09 Apr 25

Fair value Increased 0.22%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

0 votesShare

Shared on 02 Apr 25

Fair value Increased 0.44%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

0 votesShare

Shared on 26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

0 votesShare

Shared on 19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

0 votesShare

Shared on 12 Mar 25

Fair value Decreased 6.30%

AnalystConsensusTarget has decreased revenue growth from 5.4% to 4.6%.

Read more

0 votesShare